Order Article Reprints

Han O, Bromma K, Palmerley N, Bido AT, Monica M, Alhussan A, Howard PL, Brolo AG, Beckham W, Alexander AS, et al. Nanotechnology Driven Cancer Chemoradiation: Exploiting the Full Potential of Radiotherapy with a Unique Combination of Gold Nanoparticles and Bleomycin. Pharmaceutics. 2022; 14(2):233. https://doi.org/10.3390/pharmaceutics14020233

Han, Ocean, Kyle Bromma, Nicholas Palmerley, Ariadne T. Bido, Mesa Monica, Abdulaziz Alhussan, Perry L. Howard, Alexandre G. Brolo, Wayne Beckham, Abraham S. Alexander, and et al. 2022. "Nanotechnology Driven Cancer Chemoradiation: Exploiting the Full Potential of Radiotherapy with a Unique Combination of Gold Nanoparticles and Bleomycin" Pharmaceutics 14, no. 2: 233. https://doi.org/10.3390/pharmaceutics14020233

Han, O., Bromma, K., Palmerley, N., Bido, A. T., Monica, M., Alhussan, A., Howard, P. L., Brolo, A. G., Beckham, W., Alexander, A. S., & Chithrani, D. B. (2022). Nanotechnology Driven Cancer Chemoradiation: Exploiting the Full Potential of Radiotherapy with a Unique Combination of Gold Nanoparticles and Bleomycin. Pharmaceutics, 14(2), 233. https://doi.org/10.3390/pharmaceutics14020233